Concepedia

Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial

Rahim M. Naimi, Mark Hvistendahl, Lotte Hahn Enevoldsen, Jan Lysgaard Madsen, Stefan Fuglsang, Steen Seier Poulsen, Hannelouise Kissow, Jens Pedersen, Nikolaj Nerup, Rikard Ambrus,

˜The œLancet. Gastroenterology & hepatology · 2019 · 75 citations · 17 references

DOI

Concepts

References

17

ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults

Loris Pironi, Jann Arends, J. Baxter et al. · Clinical Nutrition · 2014 · 664 citations · Full text

, , +15

Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon

Palle Bekker Jeppesen, Bolette Hartmann, Jesper Thulesen et al. · Gastroenterology · 2001 · 531 citations · Full text

, , +15

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

Palle Bekker Jeppesen · Gut · 2005 · 466 citations · Full text

, , +17

Guidelines for management of patients with a short bowel

Julie Nightingale · Gut · 2006 · 405 citations · Full text

, , +12

Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2

Patricia L. Brubaker, Angelo A. Izzo, Melissa L. Hill et al. · American Journal of Physiology-Endocrinology and Metabolism · 1997 · 256 citations

, , +14